Reliance on Advance Information and Movement Sequencing in

plan. The BG, which provide internal cues necessary for component sequenc- ing, may be disrupted, .... epin, and imipramine, antidepressants; ranitidine, treatment of ulcers. 2 months ..... ory systems: a comparison of Alzheimer's, Huntington's.
806KB taille 19 téléchargements 194 vues
Movement Disorders VOI. 10, NO. 4, 1995, pp. 4 7 ~ x 1 0 1995 Movement Disorder Society

Reliance on Advance Information and Movement Sequencing in Huntington’s Disease *Nellie Georgiou, *John L. Bradshaw, *Jim G. Phillips, tEdmond Chiu, and *Judy A. Bradshaw *Department of Psychology, Monask University, Clayton; and ?‘Huntington’sDisease Clinic, University of Melbourne, Parkville, Victoria, Australia

Summary: To identify the focus of impairment in the performance of sequential movements in Huntington’s disease (HD) patients, the extent of their reliance on external advance information was examined. Twelve patients with HD and their age-matched controls performed a series of button-presses at sequential choice points along a response board. A sequential pathway was designated, and with each successive button press, advance visual information was systematically reduced to various extents in advance of each move. HD patients, like previously studied parkinsonian patients, were particularly disadvantaged with high levels of reduction in advance information, and as a consequence, both their initiation and execution of movements progressively slowed with each successive element in the response sequence. The pattern of results was not affected whether or not patients were taking neuroleptic medication, nor did performance on a variety of cognitive measures correlate with motor performance. Control subjects’ performance, on the other hand, remained constant in terms of both initiation and execution with each of the three levels of reduction in advance information. We conclude that HD patients, like parkinsonian patients, who also suffer from a basal ganglia (BG) disorder, require external visual cues to sequence motor programs effectively. Our findings suggest that with HD there may be abnormalities in a central mechanism that controls switching between movement segments within an overall motor plan. The BG, which provide internal cues necessary for component sequencing, may be disrupted, thereby impairing the ability to use such internally generated cues to guide movement. Key Words: Huntington’s diseaseAdvance information-Internal cues-Basal ganglia.

neuronal degeneration within the basal ganglia (BG) and, to a lesser extent, in other brain areas. Dysfunction and death of cells within the BG is associated with increased concentrations of dopamine, serotonin, and norepinephrine, and a decrease of y-aminobutyric acid and cholinergic synthesizing enzyme (2). Brain-imagingtechniques, such as magnetic resonance imaging (MRI) and computerized tomography (CT), have typically revealed progressive bilateral atrophy of the striatum (caudate and putamen) in the early stages of the illness and more global cortical atrophy (beginning in the frontal lobes) in its later stages (3-6). Moreover, high-

Huntington’s disease (HD) is a progressive neurodegenerative disorder, generally characterized by the onset of uncontrollable choreiform movements, impaired voluntary movements, cognitive deterioration, and affective and psychiatric symptoms. It is inherited by autosomal dominant transmission and has complete lifetime penetrance (1). The movement disorders and mental changes of HD are a consequence of progressive and selective Accepted November 26, 1994. Address correspondence and reprint requests to Dr. N . Georgiou at Psychology Department, Monash University, Clayton VIC 3168, Australia.

472

ADVANCE INFORMATION AND HUNTINGTON’S DISEASE resolution single photon emission computerized tomography (SPECT) has demonstrated significant cerebral blood flow reductions in the caudate and lentiform nuclei, as well as in the cerebral cortex, especially in the frontal and parietal regions (7). Consequently, disturbances of motor coordination and sequencing would be expected (8,9). Although chorea is the most frequent and conspicuous feature of early HD, it is only part of a much more profound and generalized disturbance of motor functioning. Akinesia (i.e., difficulty in initiating movement) and bradykinesia (i.e., difficulty in executing movement) are important and fundamental features, which may be prominent not only in the later course of the illness but also early in the disease, even when the predominant neurological sign is chorea (10). Whereas chorea may increase and then decrease as the disease progresses, akinesiahradykinesia progressively worsens (1 1). Prolonged movement times (MTs) have frequently been reported in patients suffering from both Parkinson’s disease (PD) and HD. For example, HD patients have significantly slower MTs than controls when performing repetitive tapping movements (12). Significant slowing of MT has also been reported among HD patients and certain relatives at risk of the disorder during self-paced single isometric forefinger executions and alternating forefinger movements (13). Moreover, HD patients not only may show evidence of slow MT with simple wrist flexions but may also be significantly slower in combining two movements (i.e., hand squeezing and elbow flexing) in a sequential movement task (10). The bradykinesia evident in this last study was independent of whether or not the patients were taking neuroleptic medication. Girotti et al. (14) also reported that MTs were considerably slower in HD patients as compared with controls and with parkinsonian patients. Jahanshahi et al. (15) employed a simple reaction time (SRT) and a choice reaction time (CRT) paradigm and found that HD patients had significantly longer SRT than parkinsonian patients. PD patients were able to respond faster in the SRT task compared to an uncued CRT procedure, whereas for patients with HD, this SRT/ CRT difference was not significant. Agostino et al. (16) studied the performance of sequential arm movements in HD, PD, and dystonic patients. All patient groups, especially HD patients, were considerably slowed in movement execution (i.e., MT), and in switching from one movement to the next. They also found that whereas PD patients showed a

473

progressive slowing of MT as the sequence became more complex, patients with HD did not. We find these observations surprising in terms of the pervasive BG damage caused by the disorder; indeed, we previously found that HD causes problems both in utilizing and in incorporating advance information into sequential movement (17). In a sequential button-pressing procedure, we reported (17) that HD patients have particular difficulty in executing movements at both low and very high levels of provision of advance information and in initiating movements at low levels of advance information. Very similar results were found using the same technique with parkinsonian patients (18). As with PD, HD patients seem to have difficulty in using advance information and in generating appropriate motor programs. The impairments are typically exacerbated when patients are required to conduct sequential movements using internal cues (i.e., planned programmed responses) to guide movement. We also documented progressive motor slowing in PD patients (8), which was most evident when visual information was reduced at high levels in advance of the patients’ own moves. Whereas Bradshaw et al. (17) investigated the incorporation and utilization of advance information during sequential movements by HD patients, our experiment examined their reliance on advance information; indeed, we suspect that inconsistencies in the literature may reflect the operation of such distinctions. In particular, we sought to determine the extent to which HD patients may rely on advance visual information to program and sequence motor programs. We (8) developed a serial choice button-pressing procedure that can independently assess two indices of response time-button “down time’’ (DT) and “movement time” (MT). The first, DT, is thought partly to reflect preparation time, as it measures how long each button is held down before initiating a move to the next button in the sequence. The second, MT, reflects execution time, as it measures the time “in-flight” between the release of one button and the depression of the next. This task enables a series of illuminated lights to be designated along a response board, and, with each successive button press, visual information (i.e., advance information about the pathway ahead) can be systematically reduced by extinguishing lights, to various extents, in advance of each successive move. Moreover, this task, which involves sequential forced-choice responding, also permits measurement of any progressive slowing as the se-

Movement Disorders, Vol. 10, N o . 4, 1995

N . GEORGIOU ET AL.

474

quence is traversed, as a function of how advance information is reduced. We predicted that HD patients would have difficulties in initiating and executing movements with high levels of reduction in advance information, that is, when they have to plan strategies of execution independently in advance of their own movement. We also predicted that HD patients would progressively slow in response execution as they conducted movements down the board under high levels of reduction in advance information. METHOD Subjects Twelve patients with HD and 12 age-matched controls with no history of neurological disorder participated. There were five male and seven female participants in each group, all of whom were right-handed, with a mean age of exactly 50 years for each group. Duration of HD ranged from 2 months to 10 years with a mean duration of 4 years. Severity of functional decline was assessed by a psychiatrist (E.C.), and patients fell into either stages I, 11, or 111 of the disease (19). Clinical data for the HD group, including medication, are shown in Table 1. All subjects were screened for dementia using the Short Test of Mental Status (20). A oneway analysis of variance (ANOVA) showed that scores obtained for the two groups were significantly different, F(1, 11) = 10.94, p < 0.01. To assess depression in HD, the Mood Assessment Scale was administered (21). A one-way ANOVA

showed that HD patients were significantly more ~ 0.01. depressed than controls, F(1, 11) = 1 2 . 6 2 , < Measures of attention included the Trail Making A and B tests (22), and the Stroop Interference task (23), which presents color words written in conflicting-color inks. A two-way ANOVA was conducted to compare groups on the two tasks in the Trail Making test, namely A (ascending numbers alone) and B (ascending number and letters), which revealed a significant Group by Task interaction, F(2, 22) = 28.40, p < 0.001. Post hoc one-way ANOVAs showed that both groups differed significantly in their performance on both A, F(1, 1 1 ) = 78.03, p < 0.001, and €3, F ( 1 , l l ) = 7 9 . 2 3 , ~< 0.001, indicating that the HD group was overall performing slower than the controls on both tasks. For the Stroop task, a one-way ANOVA revealed that HD patients had a significantly higher interference score than controls, F(1, 11) = 4.45, p < 0.05. Apparatus Mounted upon a response board (480 mm long by 100 mm wide) were two parallel rows of 10 target buttons (8). Each button was raised 20 mm from the board and was 13 mm in diameter (Fig. 1). Adjacent buttons were 30 mm apart, as were the rows themselves. In addition, two single buttons (Sl, S2) were sequentially pressed to initiate the task, and a further single button (F)at the other end of the board was pressed to complete a trial. Each button was illuminated by a light-emitting diode (LED) set into its base. A computer recorded the time that each button was held down (down time,

TABLE 1. Clinical data for HD patients ~~

No.

8 9 10 11 12

~~

Age (yr)

Sex

Duration of HD (yrs)

60

M

5

23

47 56 54 43 63 60

F M M F F F

8 9 2 7 10 2

3 13 1 4 6 11

45 37 51 41 40

F M F F M

2.5 0.3 3 0.2 3

Depression score

15 11 16 18 7

Medication for HD Ranitidine Tranylcypromine Dothiepin Imipramine

Haloperidol Imipramine Haloperidol Haloperidol

-

Dothiepin Haloperidol

HD, Huntington’s disease; haloperidol, neuroleptic medication; tranylcypromine, dothiepin, and imipramine, antidepressants; ranitidine, treatment of ulcers. Patients 4, 5, 6, and 10 were unmedicated. Duration of HD for patients 9 and 11 is 3 and 2 months, respectively.

Movement Disorders, Vol. 10, N o . 4, 1995

ADVANCE INFOR MA TION AND HUNTINGTON’S DISEASE

FIG. 1. Response board used in the experiment. Subjects began by pressing S1, then S2, followed by a sequence of 10 movements between successive pairs of buttons, finishing at F.

F 0000000000n u u W 0000000000

s1 s2

n n

I

4

F

480mm

DT) and the time between the release of one button and the depression of the next (movement time, MT). It also determined the button sequence to be followed (i.e., the illuminated path) at the beginning of each trial. Procedure The board was positioned across the subjects’ midline, with the two start buttons (S1 and S2) closest to the right side of the body. A pathway of illuminated lights was presented down the board, in which there were two-way choice points at each of the 10 sequential pairs of buttons. Subjects were instructed to press each illuminated button with the index finger of the right hand as quickly as possible. If a button was incorrectly pressed or was pressed twice, the trial was terminated, and the occurrence

450

475

was recorded as an error. Data from such trials were not included in the analysis, and the trial was repeated. Advance information (i.e., external visual cues) was systematically reduced in advance of the next movement in one of three ways as the subjects progressed along the board: (a) with no reduction in external cues, the next illuminated button was extinguished as the current button was released (i.e., no button extinguished in advance); (b) with moderate reduction, the next button was extinguished as the current button was depressed (i.e., one button extinguished in advance); and (c) with a high level of reduction in advance information, in addition to the next button remaining extinguished, the next-but-one button also extinguished as the current button was released. There were eight different equidistant pathways in which the numbers of linear and diagonal move-

] T

400

HD:MT

I+/

350

2

E

Y

-

0300

.-E

FIG. 2. Mean down time and movement time

against levels of reduction in advance information for both Huntington’s disease (HD) and control subjects (CON), SE bars included.

I

*----*----

4 CON: DT

No

High

Moderate

I

Levels of Reduction in Advance Information

Movement Disorders, Vol. 10. No. 4, 1995

N . GEORGIOU ET AL.

476

ments between successive button pairs were balanced, so that overall, the total distance in each movement sequence was invariant. These pathways were pseudorandomly presented across each of the three conditions, so that subjects could not predict the upcoming pathway. The different conditions were counterbalanced across subjects, with 16 experimental and six practice trials for each of the three external cue conditions. RESULTS Down Time Figure 2 shows DT plotted as a function of Reduction in Advance Information for each group. The data were submitted to a mixed two-way ANOVA (Group, Reduction in Advance Information). There was a significant main effect of Group, F(1, 22) = 37.52, p < 0.001, a significant main effect of Reduction in Advance Information, F( I , 22) = 11.65, p < 0.001, and a highly significant interaction of Group by Reduction in Advance Information, F(2,44) = 10.69, p < 0.001. Post hoc one-way ANOVAs and Tukey tests showed no significant differences for controls between any of the three levels of reduction in advance information, whereas HD patients showed significant (p < 0.01) differences between high (230 ms) and both moderate (I89 ms) and no (176 ms) reduction, but no significant differences between moderate and no reductions. Movement Time Figure 2 also provides MT data. Once again there was a significant main effect of Group, F(1, 22) = 43.13, p < 0.001, a significant main effect of Reduction in Advance Information, F(1, 22) = 8.15, p < 0.001, and a significant interaction of Group by Reduction in Advance Information, F(2, 44) = 3.33, p < 0.05. Post hoc one-way ANOVAs and Tukey tests showed no significant differences for controls between any of the three levels of reduction in advance information, whereas HD patients showed significant (p < 0.05) differences between high (377 ms) and both moderate (327 ms) and no (329 ms) reduction in advance information but no significant differences between moderate and no reductions. Sequencing Effects To determine if there was any progressive slowing across the 10 sequential response locations, trend analyses were conducted for both DT and MT. For DT, there was a significant main effect of Sequence, F(9,360) = 4.30, p < 0.001, which had a

Movement Disorders, Vol. 10, No. 4, 1995

significant (p < 0.001) linear component, and a significant interaction of Group by Sequence, F(9,720) = 4.51, p < 0.001 (Fig. 3). The highly significant three-way interaction of Group by Sequence by Reduction in Advance Information, F(18,720) = 3.13, p < 0.001, indicates that whereas controls initiated movements in a similar fashion across the board for each of the three levels of reduction, these effects were very different for HD patients, who slowed progressively down the board with a high level of reduction in advance information. For MT, similar results were found. There was a significant main effect of Sequence, F(9, 360) = 7.24, p < 0.001, which had a significant (p < 0.001) linear component, and an almost significant interaction of Group by Sequence, F(9,720) = 1.76, p < 0.07 (Fig. 3). The highly significant three-way interaction of Group by Sequence by Reduction in Advance Information, F(18, 720) = 2.87, p < 0.001, indicates that whereas controls exhibited uniform MTs across the board with each of the three levels of reduction, HD patients displayed difficulty in progressively executing movements with the most reduced level of advance information. Errors The error rate for both groups increased for high levels of reduction in advance information, as compared to the other two conditions; this effect was most pronounced in the HD data. The median errors for the three conditions (no, moderate, high) for HD patients were, 2, 4, and 13, respectively, and for controls were, 0, 2, and 4, respectively. MannWhitney U tests conducted on the error data showed that there was a significant 0, < 0.05) difference between the two groups only with high levels of reduction in advance information. Wilcoxon matched-pair tests showed that, for both groups, there were significant (p < 0.05) increases in errors with high levels of reduction in advance information. Because HD patients became slower and made more errors, we can therefore conclude that the DT and MT effects did not stem from any speedaccuracy trade-off. Medication Types The question whether medication may have affected HD performance must be addressed. Because four patients were taking neuroleptic medication, four were taking antidepressants, and four were unmedicated, we conducted a mixed threeway ANOVA for both DT and MT (neuroleptic, antidepressants, unmedicated vs. no, moderate,

ADVANCE INFORMATION AND HUNTINGTON’S DISEASE

477

- HD ---

CON Noreduction Moderate reduction High reduction

A

500 450

400

300 250

/--.

150

1

g

-

loo 50

0

0 1

2

3

4

5

6

7

8

9

10

1

2

3

4

5

6

7

8

9

10

Button number FIG. 3. Mean down time and movement time against each of the 10 sequential buttons for both Huntington’s patients (HD) and control subjects (CON).

and high levels of reduction) to determine whether or not performance across the three conditions was differentially affected by medication (Fig. 4). For DT, there was of course a main effect of Reduction in Advance Information, F(2, 18) = 11.39, p < 0.001, no main effect of Group, and no significant interaction. For MT, there was a significant main effect of Reduction in Advance Information, F(2, 18) = 6.53, p < 0.01, no main effect of Group, and again no significant interaction. Consequently the shape of the function is not substantially altered by the nature of the medication or even its absence, and irrespective of medication, HD patients were uniformly disadvantaged with high levels of reduction in advance information. Depression The absence of any effect of depression on DT and MT for HD patients can be seen from Fig. 5 . Yesavage et al. (21) stated that the cut-off for depression is 10 and above (of a maximum of 30). The propinquity of the data points renders unnecessary any further statistical treatment. Trail Making Performance The Trail Making test (22),which assesses frontal sequencing and attentional functions, had sharply

discriminated between patients and controls. Consequently Pearson product-moment correlations were conducted between both parts and each of the three cue conditions of DT and MT; however, no correlations were significant. In any case, the nonsignificant correlations for high reduction in advance information for each of parts A and B for DT were +0.48 and +0.19, respectively, and for MT were + 0.44 and + 0.45, respectively. It is therefore unlikely that performance on this cognitive measure greatly influenced motor performance. Stroop Interference Task The Stroop Interference task (23), which also assesses frontal and attentional functions, had also sharply discriminated between patients and controls. Consequently, Pearson product-moment correlations were conducted between the scores obtained on this task and each of the three cue conditions of DT and MT; however, no correlations were significant. The nonsignificant correlations for high reduction in advance information for both DT and MT were -0.29 and -0.53, respectively. Once again, performance on this cognitive measure is unlikely to influence greatly motor performance.

Movement Disorders, Vol. 10, N o . 4, 1995

478

N . GEORGIOU ET AL. 500 475

I

-neuroleptics (n = 4) --

450

-

_____

425

I

unmeditated (n = 4) antidepressants (n = 4)

400

.!375 i

-g Q)

E

‘ i ;

C

8

2

2! ’s

s

n

350 325

FIG. 4. Mean down time and movement time against levels of reduction in advance information for Huntington’s disease (HD) patients taking neuroleptic medication, antidepressants, and those unmedicated.

300 275 250 225 200 175 150 125 100

No

Moderate

High

Levels of Reduction in Advance Information

Short Test of Mental Status The overall Short Test of Mental Status (20) score showed that HD patients were significantly more cognitively impaired than were controls. To determine any possible confounding influence of this impairment on motor performance, Pearson productmoment correlations were conducted between the scores obtained on this task and each of the three cue conditions of DT and MT. Again, no correlations approached significance. The nonsignificant correlations for high reduction in advance information for both DT and MT were +0.06 and -0.08, respectively. Therefore motor performance is not simply a product of mental status. DISCUSSION

We have previously documented that HD patients experience problems in using advance information and in incorporating it into a motor program (17). In this study, we examined HD patients’ reliance on visual cues, enabling us to compare findings with previously documented deficits in patients with PD (8). As predicted, HD patients as compared to controls had considerable difficulty in initiating and executing movements with high levels of reduction in advance information, as indicated by the in-

Movement Disorders, Vol. 10, N o . 4 , 1995

creases in both DT and MT. For HD patients, whereas there was no significant increase in DT or MT between no and moderate levels of reduction, there were, however, significant increases in both the DT and MT data between moderate and high, and of course, between no and high levels of reduction in advance information. Control subjects’ performance, on the other hand, remained completely constant across each of the three conditions, for both DT and MT. In particular, under conditions of maximum reduction, unlike PD patients (8) who only slowed with MT, HD patients progressively slowed with each successive element in the response sequence for both DT and especially MT. The difficulty patients experienced with the most reduced level of advance information is also reflected in an increased error rate. Moreover, medication (its presence, or type) failed to affect the pattern of results, an observation that was also reported by Thompson et al. (10). Moreover, performance on various cognitive measures (e.g., Trail Making Test A and B, Stroop Interference Task, and the Short Test of Mental Status) failed to correlate with motor performance. Our main findings, therefore, are not likely to be simply a product of the patients’ cognitive status. HD patients are known to exhibit deficits in longterm procedural as well as declarative memory (24-

--------

ADVANCE INFORMATION AND HUNTINGTON’S DISEASE

400 450

479

Y

C

a E

FIG. 5. Mean down time and movement time against levels of reduction in advance information for Huntington’s disease (HD) patients who are and who are not depressed.

s

250 -

.-+ E

200-

z

n

150 -

100 -

28). However, we would not expect any contribution to our findings from a deficit at either level, as the pathway was not a learned sequence, and no retention interval (especially for high levels of reduction in advance information) ever exceeded 1 s. HD, as well as PD, patients experience difficulties in both initiating and in executing movements with limited visual guidance. Previous studies (10,12-14,16,17), indicated that MT may be a more sensitive indicator of HD; however, in our study, DT effects did not differ greatly from those of MT. Disturbances of voluntary movement (i.e., akinesia and bradykinesia) are useful indicators of HD functioning. Indeed, DT (reflecting akinesia) and especially MT (reflecting bradykinesia) progressively increased with each successive element in the response sequence with high levels of reduction in advance information. Contrary to our findings, Agostino et al. (16) reported that PD, but not HD, patients progressively slowed in their execution of complex motor programs. However, the repetitive sequential movements employed by those authors consisted of drawing different geometrical patterns in a counterclockwise direction, the patterns being formed by two, three, four, and five segments of identical length. Discrepancies in findings between

-not depressed (n=5) -- depressed (n=7)

the two studies may well reflect differing levels of movement uncertainty. It may be the case that HD (like PD) patients rely heavily on external visual cues to guide movement (9). With no reduction in advance information, prior programming and movement planning may be optimally realized, because patients can rely on external visual cues to initiate and execute motor programs. With high levels of reduction in advance information, however, movements need to be planned and programmed in advance, as the target path disappears from view ahead of each next move. With limited visual guidance, HD patients may require more time to plan each next submovement, and as a consequence, become less effective in using already compromised internal switching mechanisms to sequence movements progressively down the board (29). As a subject prepares to initiate a predictable, well-learned response, tonic activity builds up over the supplementary motor area (SMA), and, at release of the response, is terminated by phasic activity (an internally generated “cue”) from the globus pallidus (30-32), the output circuit of the BG. Consequently, the difficulty experienced by HD patients in switching between motor segments, and in

Movement Disorders, Vol. 10, N o . 4, 1995

N . GEORGIOU ET AL.

480

planning movements ahead of time with the most reduced level of advance information, may be partly explained by defective internal cueing (i.e., defective phasic pallidal activity) within the BG. Thus when external cues were maximally reduced in our procedure, even though the pathway was not, of course, a learned sequence per se, subjects had to maintain and continuously update an internal representation of each next pair of moves, which had previously extinguished. This BG-SMA system for mediating such an internally represented sequence is known to be compromised in PD and may well be similarly damaged in HD. Quite separately from this putative deficit, prefrontal involvement in HD is likely to extend to the lateral premotor area (33), a region adjacent to the SMA and known to be relatively much more (than the medially located SMA) involved in responding to externally derived (i.e., sensory) information (34-36). Reduction in advance information is therefore also likely to further disadvantage the already compromised premotor area. Either or both of these mechanisms could explain our findings. Acknowledgment: This work was supported by grants from the Australian Brain Foundation and Australian Research Council. We gratefully acknowledge the help of the HD patients, who gave so freely of their time. We also sincerely thank Bob Wood, Frank Devlin, Truong Nguyen, and Mike Durham for designing and maintaining the apparatus and software.

REFERENCES 1. Brandt J. Cognitive impairments in Huntington’s disease:

2. 3.

4.

5. 6. 7. 8.

insights into the neuropsychology of the striatum. In: Boller F, Grafman J, eds. Handbook of neuropsychology. New York: Elsevier Science Publishers, 1991:241-264. Shoulson I. Huntington’s disease: cognitive and psychiatric features. Neuropsychiutry Neuropsychol Behav Neurol 1990;3:15-22. Simmons JT, Pastakia B, Chase TN, Shults CW. Magnetic resonance imaging in Huntington’s disease. Am J Neuroradiol 1986;7:25-28. Starkstein SE, Brandt J, Bylsma F, Peyser C, Folstein F, Folstein SE. Neuropsychological correlates of brain atrophy in Huntington’s disease: a magnetic resonance imaging study. Neurorudiology 1992;34:487-489. Savoiardo M, Strada L, Oliva D, Girotti F, D’Incerti L. Abnormal MRI signal in the rigid form of Huntington’s disease. J Neurol Neurosurg Psychiatry 1991;54:888-891. Oliva D, Carella F, Savoiardo M, et al. Clinical and magnetic resonance features of the classic and akinetic-rigid variants of Huntington’s disease. Arch Neurol 1993;50:17-19. Hasselbalch SG, @bergG, Sgrensen SA, et al. Reduced regional cerebral blood flow in Huntington’s disease studies by SPECT. J Neurol Neurosurg Psychiatry 1992;55:1018-1023. Georgiou N , Bradshaw JL, Iansek R, Phillips JG, Mattingley JB. Reduction in external cues and movement sequencing in

Movement Disorders, Vol. 10, N o . 4, 1995

Parkinson’s disease. J Neurol Neurosurg Psychiatry 1994; 57 :368-370. 9. Georgiou N, Iansek R, Bradshaw JL, Phillips JG, Mattingley JB, Bradshaw JA. An evaluation of the role of internal cues in the pathogenesis of parkinsonian hypokinesia. Bruin 1994; 116:1575-1587. 10. Thomspson PD, Berardelli A, Rothwell JC, et al. The coexistence of bradykinesia and chorea in Huntington’s disease and its implications for theories of basal ganglia control of movement. Bruin 1988;111:223-244. 1 1 . Folstein SE, Jensen B, Leigh RJ, Folstein ML. The measurement of abnormal movement. Methods developed for Huntington’s disease. J Neurobehav Toxicol Terutol 1983; 5 :605-609. 12. Garnett ES, Firnau G , Nahmias C, Carbotte R, Bartolucci G. Reduced striatal glucose consumption and prolonged reaction time are early features of Huntington’s disease. J Neurol Sci 1984;65:231-237. 13. Hefter H, Homberg V, Lange HW, Freund HJ. Impairment of rapid movement in Huntington’s disease. Brain 1987;llO: 585-61 2. 14. Girotti F, Marano R, Soliven G, Geminiani G , Scigliano G . Relationship between motor and cognitive disorders in Huntington’s disease. J Neurol 1988;235:454-457. 15. Jahanshahi M, Brown RG, Marsden CD. A comparative study of simple and choice reaction time in Parkinson’s, Huntington’s and cerebellar disease. J Neurol Neurosurg Psychiatry 1993;56:1169-1 177. 16. Agostino R, Berardelli A, Formica A, Accornero N, Manfredi M. Sequential arm movements in patients with Parkinson’s disease, Huntington’s disease and dystonia. Bruin 1992;1 15:148 1-1495. 17. Bradshaw JL, Phillips JG, Dennis C, et al. Initiation and execution of movement sequences in those suffering from and at risk of developing Huntington’s disease. J Clin Exp Neuropsychol 1992;14:179-192. 18. Jones DL, Phillips JG, Bradshaw JL, Iansek R, Bradshaw JA. Programming of single movements in Parkinson’s disease: comparison with Huntington’s disease. J Clin Exp Neuropsychol 1992;14:762-772. 19. Shoulson I, Fahn S. Huntington’s disease: clinical care and evaluation. Neurology 1979;29:1-3. 20. Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC. The Short Test of Mental Status: correlations with standardised psychometric testing. Arch Neurol 1991;48:725-728. 21. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression rating scale: a preliminary report. J Psychiatr Res 1983;17:37-49. 22. Reitan RM. Validity of the Trail Making Test as an indication of organic brain damage. Percep Motor Skills 1958;8: 271-276. 23. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psycho1 1935;18:643-662. 24. Heindel WC, Butters N, Salmon DP. Impaired learning of a motor skill in patients with Huntington’s disease. Behav Neurosci 1988;102:141-147. 25. Heindel WC, Salmon DP, Shults CW, Walicke PA, Butters N. Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer’s, Huntington’s and Parkinson’s disease patients. J Neurosci 1989;9:582521

26. Knopman D, Nissen MJ. Procedural learning is impaired in Huntington’s disease: evidence from the serial reaction time task. Neuropsychologia 1991;29:245-254. 27. Martone M, Butters N, Payne P. Dissociations between skill learning and verbal recognition in amnesia and dementia. Arch Neurol 1984;41:965-970. 28. Saint-Cyr JA, Taylor AE, Lang AE. Procedural learning and neostriatal dysfunction in man. Bruin 1988;111:941-959.

ADVANCE INFORMATION AND HUNTINGTON'S DISEASE 29. Marsden CD. Neurophysiology. In: Stern GM, ed. Parkinson's disease. London: Chapman & Hall, 199057-98. 30. Brotchie lamek R s Home MK. Motor function Of the monkey globus pallidus: neuronal discharge and parameters of movement. Brain 1991;114:1667-1683. 31. Brotchie P, Iansek R, Home MK. Motor function of the monkey globus pallidus: cognitive aspects of movement and phasic neuronal activity. Bruin 1991;114:1685-1702. 32. Ikeda A, Luders H, Burgess R, Shibasaki H. Movementrelated potentials recorded from supplementary motor area and primary motor area: role of supplementary motor area in voluntary movements. Brain 1992;115:1017-1043. 33. Schell GR, Strick PL. The origin of thalamic inputs to the '9

481

arcuate premotor and supplementary motor areas. J Neurosci 1984;4:539-560.

34. Jones EG, Coulter JD, Hendry SH. Intracortical connectivity of architectonic fields in the somatic sensory, motor and parietal cortex of monkeys. J Comp Neurol 1978;181:291347. 35. Okano K. Temporal priority of premotor cortex over nearby areas in receiving visual cues in primates. Neuroreport 1992; 3:38%392. 36. Petrides M, Pandya DN. Projections to the frontal cortex from the posterior parietal region in the rhesus monkey. J Comp Neurol 1984;228:105-1 16.

Movement Disorders, Vol. 10, N o . 4, 1995